Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000079183 | SCV000111052 | benign | not specified | 2013-07-31 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000079183 | SCV000305065 | benign | not specified | 2018-04-02 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000348452 | SCV000412608 | likely benign | Central core myopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000405734 | SCV000412609 | likely benign | Neuromuscular disease, congenital, with uniform type 1 fiber | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000313484 | SCV000412610 | likely benign | Malignant hyperthermia of anesthesia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000370460 | SCV000412611 | likely benign | Multiminicore myopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000544088 | SCV000660075 | benign | RYR1-related disorder | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000079183 | SCV000726243 | benign | not specified | 2018-01-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Breakthrough Genomics, |
RCV004703213 | SCV005207173 | likely benign | not provided | criteria provided, single submitter | not provided |